Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.08T
Market cap1.08T
Price-Earnings ratio
38.83
Price-Earnings ratio38.83
Dividend yield
0.59%
Dividend yield0.59%
Average volume
2.27M
Average volume2.27M
High today
$1,165.73
High today$1,165.73
Low today
$1,139.50
Low today$1,139.50
Open price
$1,149.17
Open price$1,149.17
Volume
1.06M
Volume1.06M
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$783.85
52 Week low$783.85

Stock Snapshot

With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,149.34. The stock has a price-to-earnings ratio of 38.83 and currently yields dividends of 0.59%.

During the trading session on 2026-10-05, Eli Lilly(LLY) shares reached a daily high of $1,165.73 and a low of $1,139.50. At a current price of $1,149.34, the stock is +0.9% higher than the low and still -1.4% under the high.

Trading activity shows a volume of 1.06M, compared to an average daily volume of 2.27M.

The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.

The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.

LLY News

TipRanks 54m
Eli Lilly Stock Gains on Regulatory Win for Experimental Cancer Drug

The stock of Eli Lilly (LLY) is up about 1% on Oct. 5 after the company secured a regulatory win for one of its experimental cancer drugs called Olomorasib. The...

The Motley Fool 4h
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled - The Motley Fool

...

This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled - The Motley Fool
TipRanks 4h
Eli Lilly treatment of pancreatic cancer granted orphan designation

Eli Lilly (LLY) was granted FDA orphan designation for olomorasib for the treatment of pancreatic cancer, according to a post to the agency’s website. Publishe...

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
9.4%
Sell
6.3%

More LLY News

Benzinga 6h
FDA Expands Approval for Eli Lilly Therapy in Untreated Leukemia Patients

The U.S. Food and Drug Administration on Friday approved an additional indication of Jaypirca (pirtobrutinib), enabling Eli Lilly and Co. (NYSE:LLY) to market t...

FDA Expands Approval for Eli Lilly Therapy in Untreated Leukemia Patients
The Motley Fool 7h
Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Is it better to pay a premium for explosive growth or hunt for value in a steady giant? This is the central question for investors choosing between Eli Lilly (L...

Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool 1d
Forget Zepbound: Eli Lilly's Next Weight-Loss Drug Could Be Its Biggest Blockbuster Yet

Healthcare stocks have lagged broader equities over the past few years, but the company that is now the largest in that sector, Eli Lilly (LLY -0.61%), has deli...

Forget Zepbound: Eli Lilly's Next Weight-Loss Drug Could Be Its Biggest Blockbuster Yet
The Motley Fool 1d
Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.

Eli Lilly (LLY -0.61%) has been making the headlines for one particular reason over the last few years. It dominates in an area that has captured the general pu...

Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
The Motley Fool 2d
Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.

Bond yields are rising, inflation remains above the Federal Reserve's target, and there has already been one Fed rate hike. Wall Street is bracing for further r...

Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.
Simply Wall St 3d
Eli Lilly Posts Drug Trial Wins As Pipeline Progress Meets Legal Setbacks

Eli Lilly (NYSE:LLY) reported new clinical data on obesity drug Foundayo, diabetes candidate EloraTZP, and dermatitis therapy EBGLYSS, alongside plans for regul...

Eli Lilly Posts Drug Trial Wins As Pipeline Progress Meets Legal Setbacks
TipRanks 3d
Eli Lilly announces FDA approves additional indication for Jaypirca

Eli Lilly (LLY) and Company announced that the U.S. Food and Drug Administration FDA has approved an additional indication for Jaypirca, a non-covalent Bruton t...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.